12:00 AM
 | 
Oct 07, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Impact Dx Factor V Leiden and Factor II Genotyping Test regulatory update

Sequenom submitted 510(k) applications to FDA for the Impact Dx Factor V Leiden and Factor II Genotyping Test as an aid in the diagnosis of...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >